Lung Cancer Screening (PDQ®)–Health Professional Version
SECTIONS
- Overview
- Description of the Evidence
- Harms of Screening
- Informed Medical Decision Making
- Changes to This Summary (09/29/2017)
- About This PDQ Summary
- View All Sections
Changes to This Summary (09/29/2017)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
Added text about a third study from the U.K. Lung Cancer Screening pilot trial of a low-dose computed tomography (CT) scan that found that screening was associated with a statistically significant increase in short- and long-term smoking cessation; this effect was greatest among those whose initial screening test was positive, warranting additional clinical investigation (cited Brain et al. as reference 17).
Revised text to state that the results of these studies suggest that the net impact of a CT program on smoking cessation varied, but there appears to be a higher likelihood of smoking cessation among current smokers who have findings suspicious for lung cancer.
This summary is written and maintained by the PDQ Screening and Prevention Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.
No hay comentarios:
Publicar un comentario